Literature DB >> 26926408

Hypertensive Disorders of Pregnancy.

Lawrence Leeman1, Lee T Dresang2, Patricia Fontaine3.   

Abstract

Elevated blood pressure in pregnancy may represent chronic hypertension (occurring before 20 weeks' gestation or persisting longer than 12 weeks after delivery), gestational hypertension (occurring after 20 weeks' gestation), preeclampsia, or preeclampsia superimposed on chronic hypertension. Preeclampsia is defined as hypertension and either proteinuria or thrombocytopenia, renal insufficiency, impaired liver function, pulmonary edema, or cerebral or visual symptoms. Proteinuria is not essential for the diagnosis and does not correlate with outcomes. Severe features of preeclampsia include a systolic blood pressure of at least 160 mm Hg or a diastolic blood pressure of at least 110 mm Hg, platelet count less than 100 × 103 per µL, liver transaminase levels two times the upper limit of normal, a doubling of the serum creatinine level or level greater than 1.1 mg per dL, severe persistent right upper-quadrant pain, pulmonary edema, or new-onset cerebral or visual disturbances. Preeclampsia without severe features can be managed with twice-weekly blood pressure monitoring, antenatal testing for fetal well-being and disease progression, and delivery by 37 weeks' gestation. Preeclampsia with any severe feature requires immediate stabilization and inpatient treatment with magnesium sulfate, antihypertensive drugs, corticosteroids for fetal lung maturity if less than 34 weeks' gestation, and delivery plans. Preeclampsia can worsen or initially present after delivery. Women with hypertensive disorders should be monitored as inpatients or closely at home for 72 hours postpartum.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26926408

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  20 in total

1.  Temporal Trends of Hospitalization, Mortality, and Financial Impact Related to Preeclampsia with Severe Features in Hawai'i and the United States.

Authors:  Ji Hae Lee; Guangxiang Zhang; Scott Harvey; Kazuma Nakagawa
Journal:  Hawaii J Health Soc Welf       Date:  2019-08

Review 2.  Obesity "complements" preeclampsia.

Authors:  Kelsey N Olson; Leanne M Redman; Jenny L Sones
Journal:  Physiol Genomics       Date:  2019-02-04       Impact factor: 3.107

3.  Celecoxib restores angiogenic factor expression at the maternal-fetal interface in the BPH/5 mouse model of preeclampsia.

Authors:  Dorien Reijnders; Chin-Chi Liu; Xinjing Xu; Anna M Zhao; Kelsey N Olson; Scott D Butler; Nataki C Douglas; Jenny L Sones
Journal:  Physiol Genomics       Date:  2018-03-09       Impact factor: 3.107

Review 4.  Hypertensive disorders in pregnancy.

Authors:  Casey Berry; Mohamed G Atta
Journal:  World J Nephrol       Date:  2016-09-06

5.  Adverse metabolic phenotype of female offspring exposed to preeclampsia in utero: a characterization of the BPH/5 mouse in postnatal life.

Authors:  Elizabeth F Sutton; Heinrich E Lob; Jiunn Song; YunWei Xia; Scott Butler; Chin-Chi Liu; Leanne M Redman; Jenny L Sones
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-01-25       Impact factor: 3.619

6.  The decidua of preeclamptic-like BPH/5 mice exhibits an exaggerated inflammatory response during early pregnancy.

Authors:  C Y Heyward; J L Sones; H E Lob; L C Yuen; K E Abbott; W Huang; Z R Begun; S D Butler; A August; C A Leifer; R L Davisson
Journal:  J Reprod Immunol       Date:  2017-04-10       Impact factor: 4.054

7.  Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice.

Authors:  Jeremy A Sandgren; Guorui Deng; Danny W Linggonegoro; Sabrina M Scroggins; Katherine J Perschbacher; Anand R Nair; Taryn E Nishimura; Shao Yang Zhang; Larry N Agbor; Jing Wu; Henry L Keen; Meghan C Naber; Nicole A Pearson; Kathy A Zimmerman; Robert M Weiss; Noelle C Bowdler; Yuriy M Usachev; Donna A Santillan; Matthew J Potthoff; Gary L Pierce; Katherine N Gibson-Corley; Curt D Sigmund; Mark K Santillan; Justin L Grobe
Journal:  JCI Insight       Date:  2018-10-04

8.  Differential body weight, blood pressure and placental inflammatory responses to normal versus high-fat diet in melanocortin-4 receptor-deficient pregnant rats.

Authors:  Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  J Hypertens       Date:  2016-10       Impact factor: 4.844

9.  Impact of gestational risk factors on maternal cardiovascular system.

Authors:  María Perales; Alejandro Santos-Lozano; Fabian Sanchis-Gomar; María Luaces; Helios Pareja-Galeano; Nuria Garatachea; Rubén Barakat; Alejandro Lucia
Journal:  Ann Transl Med       Date:  2016-07

Review 10.  Preeclampsia, of mice and women.

Authors:  Jenny L Sones; Robin L Davisson
Journal:  Physiol Genomics       Date:  2016-06-03       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.